Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer

BACKGROUND: Trophoblast cell-surface antigen 2 (TROP2) is related to tumor proliferation enhancement and poor prognosis. An antibody targeting TROP2 was developed to treat metastatic triple-negative breast cancer (TNBC) which has a limited treatment modality. To characterize the TROP2 expressing tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Yeonjin, Jo, Uiree, Hong, Jongmoo, Gong, Gyungyub, Lee, Hee Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509625/
https://www.ncbi.nlm.nih.gov/pubmed/36153494
http://dx.doi.org/10.1186/s12885-022-10076-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509625/
https://www.ncbi.nlm.nih.gov/pubmed/36153494
http://dx.doi.org/10.1186/s12885-022-10076-7

Ejemplares similares